Big Pharma news from FierceBiotech
News
Fund manager: Pharmas must buy biotechs--or die
Some of the smartest money on Wall Street is betting that the hot pace of biotech buyouts still has a long way to run. Andrej Hrovat, who runs the RH&Partner Global Life Science Fund, says... Read more...
Pharma finds promise, peril in biotech revolution
The problem with the European pharmaceuticals industry--at least in part--is... Read more...
Get more Big Pharma coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
